Top Markets
Coin of the day
Firebrick Pharma Limited Firebrick Pharma Limited

Firebrick Pharma Limited

FRE
Rank in Stocks #35032
Firebrick Pharma Limited, an enterprise established in 2012 and headquartered... Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.
Share Price
$0.01904269
Last synced: 2026-08-14
Market Cap
$4.55M
Change (1 day)
0.00%
Change (1 year)
-63.41%
Country
AU
Trade Firebrick Pharma Limited (FRE)

Category

Operating Margin for Firebrick Pharma Limited (FRE)
Operating Margin as of 2026 TTM: 0.00%
According to Firebrick Pharma Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Firebrick Pharma Limited from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
43.92% -
US
26.81% -
US
29.32% -
US
26.59% -
CH
16.65% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.